29.05.2022, 1864 Zeichen
Valneva: Valneva, an Austrian/French specialty vaccine company, today announced the successful completion of the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The final analysis included six-month follow-up data and confirmed the topline results reported in December 2021. The VLA1553-302 trial met its primary endpoint, demonstrating that three consecutively manufactured vaccine lots elicited equivalent immune responses measured by neutralizing antibody titer GMT ratios on Day 29 after vaccination.
Valneva: weekly performance:
EVN: Revenue recorded by Austrian utility company EVN Group rose by 65.5% to Euro 2,126.7m in the first half of 2021/22, based on a variety of individual factors: In South East Europe, the upsurge in electricity prices led to sound growth in energy distribution while weather-related volume effects were responsible for higher network revenue. In Austria, the network tariffs set by E-Control as of 1 January 2021 and 1 January 2022 had a positive influence on network revenue. Other important impulses were provided by price effects from renewable electricity generation and positive valuation effects from hedges. The more frequent use of the Theiss power plant by the Austrian transmission network operator for network stabilisation generally offset the revenue lost from the Walsum 10 power plant following the sale of EVN’s investment and the termination of electricity purchases from this source. Growth was also recorded in the international project business. EBITDA recorded by the EVN Group fell by 21.6% year-on-year to Euro 420.2m in the first half of 2021/22. Group net result for the period equalled Euro 127.4m. This represents a year-on-year decline of 27.6%.
EVN: weekly performance:
(From the 21st Austria weekly https://www.boerse-social.com/21staustria (26/05/2022)
D&D Research Rendezvous #22: Gunter Deuber mit Blick auf den ATX, besonderen Blick auf AT&S, dazu Notenbanken, Standort, KI und Treasury
Aktien auf dem Radar:AT&S, Lenzing, Strabag, Austriacard Holdings AG, Semperit, EuroTeleSites AG, Erste Group, FACC, Addiko Bank, voestalpine, Rosgix, Fabasoft, Mayr-Melnhof, Agrana, CPI Europe AG, Telekom Austria, BKS Bank Stamm, Wolford, Amag, Österreichische Post, Symrise, Fresenius Medical Care, Fresenius, Rheinmetall, Deutsche Telekom, Brenntag, SAP, Volkswagen Vz., DAIMLER TRUCK HLD..., Deutsche Post, Siemens Healthineers.
Matejka & Partner
Die Matejka & Partner Asset Management GmbH ist eine auf Vermögensverwaltung konzentrierte Wertpapierfirma. Im Vordergrund der Dienstleistungen stehen maßgeschneiderte Konzepte und individuelle Lösungen. Für die Gesellschaft ist es geübte Praxis, neue Herausforderungen des Marktes frühzeitig zu erkennen und entsprechende Strategien zu entwickeln.
>> Besuchen Sie 55 weitere Partner auf boerse-social.com/partner
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten